Joseph Beaulieu, Corporate Controller at Epizyme, Inc. (EPZM), sold 203 shares at $12.10 ($2K) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Scheduled sale ($2k) by Corporate Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2021-02-05 | $3K | — | Filing → |
| EPZM | SELL | 2020-09-03 | $19K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $5K | — | Filing → |